Challenge
The client was inspired to be an industry leader in gene therapy and had a broad portfolio of early-stage assets. Leadership had a goal of launching multiple assets in the near-term but identified pipeline gap in their portfolio. The client wanted to develop a portfolio strategy to mitigate this gap and enhance its market position.
Approach
We conducted a situational assessment to identify the client's strengths and weaknesses. Next, we conducted secondary research to characterize competitors and interviewed strategy and BD SMEs to understand landscape dynamics and pipeline scale needed for near-term leadership. Portfolio options were assessed in Leadership team workshops; outputs supported formation of a multi-year portfolio strategy and roadmap.
Impact
The client was aligned to the proposed portfolio strategy, principles and composition. Recommendations supported future external program acquisitions.
